Professor of Urology and Director of Urologic Oncology Fellowship, M.D. Anderson Cancer Center
BIOGRAPHY
Speaker
Event Date & Time
DATE: January 16th, 2019
TIME: 9:00AM PST, 12:00PM EST
Abstract
Dr. Kamat will present his clinical experience using molecular markers, in addition to the standard of care, to examine patient outcomes in the BCG response monitoring scenario.
Learning Objectives:
- Review of Bladder Cancer case studies to understand the use of BCG in bladder cancer subtypes
- Understand BCG tolerance, patient response, and use of UroVysion
You May Also Like
OCT 02, 2024 | 7:30 AM
De novo gene synthesis and protein expression are established technologies that can give access to nearly any target DNA or protein sequence, allowing for engineering of biologics. In this p...
DEC 10, 2024 | 9:00 AM
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
Loading Comments...